Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trapani

Showing results (311-320 of 351) with videos related to

Pageof 36
Sort By:
Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.
Blood|January 26, 2022
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1Daniela Castiblanco, Jesse A Rudd-Schmidt, Tahereh Noori, et al.
Journal of Medicinal Chemistry|September 19, 2019
Inhibition of the Cytolytic Protein Perforin Prevents Rejection of Transplanted Bone Marrow Stem Cells in VivoJulie A Spicer, Christian K Miller, Patrick D O'Connor, et al.
ACS Pharmacology & Translational Science|June 17, 2022
Preclinical Activity and Pharmacokinetic/Pharmacodynamic Relationship for a Series of Novel Benzenesulfonamide Perforin InhibitorsKate H Gartlan, Jagdish K Jaiswal, Matthew R Bull, et al.
Plos Pathogens|December 16, 2014
A natural genetic variant of granzyme B confers lethality to a common viral infectionChristopher E Andoniou, Vivien R Sutton, Matthew E Wikstrom, et al.
Cancer Research|August 21, 2020
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune EvasionFlorida Voli, Emanuele Valli, Luigi Lerra, et al.
Journal of Medicinal Chemistry|November 8, 2013
Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforinJulie A Spicer, Gersande Lena, Dani M Lyons, et al.
Oncoimmunology|September 26, 2015
Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomibPaul J Neeson, Andy K Hsu, Yin R Chen, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Nature Communications|September 2, 2023
Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer modelsL H Porter, J J Zhu, N L Lister, et al.
Pageof 36

Showing results (311-320 of 351) with videos related to

Sort By:
Pageof 36
Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.
Blood|January 26, 2022
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1Daniela Castiblanco, Jesse A Rudd-Schmidt, Tahereh Noori, et al.
Journal of Medicinal Chemistry|September 19, 2019
Inhibition of the Cytolytic Protein Perforin Prevents Rejection of Transplanted Bone Marrow Stem Cells in VivoJulie A Spicer, Christian K Miller, Patrick D O'Connor, et al.
ACS Pharmacology & Translational Science|June 17, 2022
Preclinical Activity and Pharmacokinetic/Pharmacodynamic Relationship for a Series of Novel Benzenesulfonamide Perforin InhibitorsKate H Gartlan, Jagdish K Jaiswal, Matthew R Bull, et al.
Plos Pathogens|December 16, 2014
A natural genetic variant of granzyme B confers lethality to a common viral infectionChristopher E Andoniou, Vivien R Sutton, Matthew E Wikstrom, et al.
Cancer Research|August 21, 2020
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune EvasionFlorida Voli, Emanuele Valli, Luigi Lerra, et al.
Journal of Medicinal Chemistry|November 8, 2013
Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforinJulie A Spicer, Gersande Lena, Dani M Lyons, et al.
Oncoimmunology|September 26, 2015
Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomibPaul J Neeson, Andy K Hsu, Yin R Chen, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Nature Communications|September 2, 2023
Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer modelsL H Porter, J J Zhu, N L Lister, et al.
Pageof 36